Like many micro-cap biotechnology and pre-revenue medical technology equities, Quantum-Si has experienced varying levels of short interest as skeptical traders target companies with high cash burn rates and early-stage commercial rollouts. Short interest metrics fluctuate periodically based on broader small-cap market sentiment, quarterly earnings disclosures, and institutional reports tracking short-term bearish bets against developmental life-science companies.